GAMMA Investing’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$176K Sell
2,352
-165
-7% -$13.1K 0.01% 1435
2026
Q2
$199K Sell
2,517
-416
-14% -$35.4K 0.01% 1273
2026
Q1
$253K Buy
2,933
+574
+24% +$51.5K 0.01% 955
2025
Q4
$206K Buy
2,359
+921
+64% +$69.9K 0.01% 1019
2025
Q3
$82.4K Buy
1,438
+184
+15% +$10.6K ﹤0.01% 1646
2025
Q2
$74K Sell
1,254
-260
-17% -$16.8K ﹤0.01% 1651
2025
Q1
$111K Buy
1,514
+256
+20% +$21.2K 0.01% 1168
2024
Q4
$104K Buy
1,258
+370
+42% +$29.2K 0.01% 1084
2024
Q3
$63.5K Buy
888
+257
+41% +$18.1K 0.01% 1316
2024
Q2
$43.2K Buy
631
+453
+254% +$27.1K 0.01% 1303
2024
Q1
$9.55K Buy
178
+28
+19% +$1.5K ﹤0.01% 2093
2023
Q4
$7.92K Buy
+150
New +$7.31K ﹤0.01% 2028

Other funds holding GMED

GAMMA Investing's GMED Position: Q3 2026 in Review

GAMMA Investing reduced its Globus Medical (GMED) stake by 6.6% in Q3 2026, selling an estimated $13.1K and leaving 2,352 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #1435.

GAMMA Investing first reported a position in GMED in Q4 2023 and has held it in 12 quarters since. The position peaked at $253K in Q1 2026. 22 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • GAMMA Investing held 2,352 shares of Globus Medical worth $176K as of Q3 2026.
  • GAMMA Investing sold 165 Globus Medical shares in Q3 2026, an estimated $13.1K.
  • Globus Medical made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1435 holding.
  • GAMMA Investing first reported a position in Globus Medical in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Globus Medical position peaked at $253K in Q1 2026.
  • 22 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.